Eqis Capital Management, Inc. Bio Rad Laboratories, Inc. Transaction History

Eqis Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $331,183 - $397,873	791 New	791 $378,000
Q2 2020 Aug 10, 2020	SELL	$334.87 - $493.06 $228,716 - $336,759	-683 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$320.01 - $409.07 $4,480 - $5,726	14 Added 2.09%	683 $253,000
Q4 2019 Jan 24, 2020	BUY	$319.73 - $374.2 $213,899 - $250,339	669 New	669 $247,000
Q2 2019 Jul 18, 2019	SELL	$286.93 - $312.59 $377,312 - $411,055	-1,315 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$224.3 - $317.41 $294,954 - $417,394	1,315 New	1,315 $402,000

457

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.19B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Eqis Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Eqis Capital Management, Inc. with notifications on news.